olanzapine LAI (TEV-'749) / Royalty, Teva, MedinCell  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
olanzapine LAI (TEV-'749) / Teva, MedinCell
NCT06315283: An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

Recruiting
1
116
Europe, US, RoW
TV-44749, Olanzapine, Oral olanzapine, ZYPREXA®
Teva Branded Pharmaceutical Products R&D, Inc.
Schizophrenia
04/25
04/25
NCT06253546: Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Recruiting
1
36
RoW
TV-44749, Oral Olanzapine, ZYPREXA
Teva Branded Pharmaceutical Products R&D, Inc.
Schizophrenia
01/25
01/25
NCT06319170: Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Recruiting
1
95
US
Olanzapine Extended Release, Olanzapine, ZYPREXA
Teva Branded Pharmaceutical Products R&D, Inc.
Schizophrenia, Schizoaffective Disorder
12/24
12/24

Download Options